Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Exogenous schwann cells migrate, remyelinate and promote clinical recovery in experimental auto-immune encephalomyelitis.
The influence of ethnicity on the characteristics of multiple sclerosis: A local population study between Persians and Arabs.
Acorda Therapeutics announces positive AMPYRA® (dalfampridine) Phase 2 data in people with post-stroke deficits
Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
Genzyme’s Lemtrada™ approved in Canada for treatment of multiple sclerosis
Conformational Landscape of N-Glycosylated Peptides Detecting Autoantibodies in Multiple Sclerosis, Revealed by Hamiltonian Replica Exchange.
Optimizing parameter choice for FSL-Brain Extraction Tool (BET) on 3D T1-images in multiple sclerosis.
Serological evidence of increased susceptibility to varicella-zoster virus reactivation or reinfection in natalizumab-treated patients with multiple sclerosis.
Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus.
"Tell me what you want, what you really really want….": asking people with multiple sclerosis about enhancing their participation in physical activity.
UVB light attenuates the systemic immune response in CNS autoimmunity.
Neural differentiation of patient specific iPS cells as a novel approach to study the pathophysiology of multiple sclerosis.
A comparative study of experimental mouse models of central nervous system demyelination.
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality.
Long-term clinical and magnetic resonance imaging outcomes from patients treated with teriflunomide: Results from a phase 2 extension study.
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
Laminin-411 Is a Vascular Ligand for MCAM and Facilitates TH17 Cell Entry into the CNS.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
Medical marijuana: clearing away the smoke.
Managing fatigue in patients with multiple sclerosis.
Excess of melanocytic nevi in a patient treated with natalizumab for multiple sclerosis.
Eicosapentaenoic acid (EPA) induces peroxisome proliferator-activated receptors and ameliorates experimental autoimmune encephalomyelitis.
Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.

Pages